Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoine

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2008
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric studyY Belkacémi, J Gligorov, M Ozsahin, et al.
La Revue De Medecine Interne|April 26, 2023
[Autoimmune and inflammatory pathologies associated with systemic scleroderma: Clinical, serological and prognostic profiles. Bi-centric retrospective series in the PACA region]T Hübsch, C Mettler, E Poisnel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancerD Khayat, P Chollet, E C Antoine, et al.
The Cancer Journal From Scientific American|February 11, 1998
Salpêtrière Hospital experience with biochemotherapy in metastatic melanomaE C Antoine, A Benhammouda, A Bernard, et al.
European Journal of Neurology|July 13, 2006
Management of paraneoplastic neurological syndromes: report of an EFNS Task ForceC A Vedeler, J C Antoine, B Giometto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodiesJ Honnorat, S Cartalat-Carel, D Ricard, et al.
The European Journal of Neuroscience|December 14, 1999
Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromesJ Honnorat, T Byk, I Kusters, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2004
Recommended diagnostic criteria for paraneoplastic neurological syndromesF Graus, J Y Delattre, J C Antoine, et al.
La Revue De Medecine Interne|January 13, 2006
[Sirolimus-associated interstitial pneumonitis in a renal transplant patient]C Bauer, O Lidove, C Lamotte, et al.
Brain : a Journal of Neurology|August 1, 1997
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndromeW P Mason, F Graus, B Lang, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2008
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric studyY Belkacémi, J Gligorov, M Ozsahin, et al.
La Revue De Medecine Interne|April 26, 2023
[Autoimmune and inflammatory pathologies associated with systemic scleroderma: Clinical, serological and prognostic profiles. Bi-centric retrospective series in the PACA region]T Hübsch, C Mettler, E Poisnel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancerD Khayat, P Chollet, E C Antoine, et al.
The Cancer Journal From Scientific American|February 11, 1998
Salpêtrière Hospital experience with biochemotherapy in metastatic melanomaE C Antoine, A Benhammouda, A Bernard, et al.
European Journal of Neurology|July 13, 2006
Management of paraneoplastic neurological syndromes: report of an EFNS Task ForceC A Vedeler, J C Antoine, B Giometto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodiesJ Honnorat, S Cartalat-Carel, D Ricard, et al.
The European Journal of Neuroscience|December 14, 1999
Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromesJ Honnorat, T Byk, I Kusters, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2004
Recommended diagnostic criteria for paraneoplastic neurological syndromesF Graus, J Y Delattre, J C Antoine, et al.
La Revue De Medecine Interne|January 13, 2006
[Sirolimus-associated interstitial pneumonitis in a renal transplant patient]C Bauer, O Lidove, C Lamotte, et al.
Brain : a Journal of Neurology|August 1, 1997
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndromeW P Mason, F Graus, B Lang, et al.
Pageof 30